Get the Stockscreener App
0.00
100.00%
-8.68
Sage Therapeutics Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.
See More
Previous Close:
$8.68
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$544.94M
Revenue:
$91.06M
Net Income/Loss:
$-503.14M
P/E Ratio:
0.00
EPS:
-8.39
Net Cash Flow:
$-424.74M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$9.36
Sage Therapeutics Inc Stock (SAGE) Company Profile
Name
Sage Therapeutics Inc
Sector
Industry
Phone
617-299-8380
Address
55 CAMBRIDGE PARKWAY, CAMBRIDGE, MA
Compare SAGE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SAGE
Sage Therapeutics Inc
|
0.00 | 544.94M | 91.06M | -503.14M | -424.74M | -8.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
384.59 | 98.23B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
598.54 | 62.74B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.75 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
740.95 | 45.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
338.50 | 36.81B | 3.81B | -644.79M | -669.77M | -6.24 |
Sage Therapeutics Inc Stock (SAGE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-11-25 | Resumed | BofA Securities | Underperform |
| Nov-21-24 | Upgrade | RBC Capital Mkts | Underperform → Sector Perform |
| Oct-10-24 | Resumed | Raymond James | Mkt Perform |
| Oct-04-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jul-30-24 | Downgrade | TD Cowen | Buy → Hold |
| Jul-25-24 | Downgrade | JP Morgan | Overweight → Neutral |
| May-29-24 | Initiated | Citigroup | Sell |
| May-29-24 | Initiated | Robert W. Baird | Neutral |
| Apr-17-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-12-23 | Initiated | Deutsche Bank | Hold |
| Aug-08-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-08-23 | Downgrade | Goldman | Buy → Neutral |
| Aug-08-23 | Downgrade | Needham | Buy → Hold |
| Aug-07-23 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-07-23 | Downgrade | Oppenheimer | Outperform → Perform |
| Aug-07-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Aug-07-23 | Downgrade | Stifel | Buy → Hold |
| Aug-07-23 | Downgrade | Wedbush | Outperform → Neutral |
| Jul-27-23 | Initiated | Scotiabank | Sector Outperform |
| Mar-13-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-03-23 | Downgrade | Guggenheim | Buy → Neutral |
| Nov-01-22 | Initiated | Loop Capital | Hold |
| Mar-31-22 | Initiated | Berenberg | Hold |
| Nov-02-21 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-19-21 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-07-21 | Downgrade | Jefferies | Buy → Hold |
| Sep-23-21 | Initiated | Needham | Buy |
| Jun-16-21 | Downgrade | Citigroup | Buy → Neutral |
| Apr-07-21 | Initiated | Piper Sandler | Overweight |
| Feb-26-21 | Downgrade | Mizuho | Buy → Neutral |
| Feb-25-21 | Reiterated | H.C. Wainwright | Neutral |
| Feb-02-21 | Resumed | Raymond James | Mkt Perform |
| Jan-22-21 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jan-04-21 | Upgrade | Guggenheim | Neutral → Buy |
| Jan-04-21 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-04-20 | Upgrade | Mizuho | Neutral → Buy |
| Dec-01-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Nov-16-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-06-20 | Reiterated | H.C. Wainwright | Neutral |
| Sep-11-20 | Upgrade | Wedbush | Neutral → Outperform |
| Aug-10-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-08-20 | Downgrade | Wedbush | Outperform → Neutral |
| Apr-08-20 | Downgrade | Guggenheim | Buy → Neutral |
| Mar-18-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Mar-06-20 | Initiated | Citigroup | Buy |
| Feb-28-20 | Reiterated | H.C. Wainwright | Neutral |
| Feb-06-20 | Initiated | Mizuho | Neutral |
| Dec-06-19 | Reiterated | RBC Capital Mkts | Outperform |
| Dec-05-19 | Reiterated | Guggenheim | Buy |
| Dec-05-19 | Downgrade | SunTrust | Buy → Hold |
| Oct-30-19 | Initiated | H.C. Wainwright | Neutral |
| May-23-19 | Initiated | Wedbush | Outperform |
| Apr-25-19 | Initiated | Jefferies | Buy |
| Dec-14-18 | Initiated | Wolfe Research | Outperform |
| Oct-11-18 | Initiated | Oppenheimer | Outperform |
View All
Sage Therapeutics Inc Stock (SAGE) Latest News
Volatility clustering patterns for Sage Therapeutics Inc.July 2025 Trade Ideas & Daily Chart Pattern Signal Reports - newser.com
ETF Watch: Is Sage Therapeutics Inc impacted by rising ratesMarket Performance Recap & Safe Capital Investment Plans - خودرو بانک
Guidance Update: Can Sage Therapeutics Inc maintain sales growthPortfolio Performance Report & Fast Gain Stock Trading Tips - خودرو بانک
Macro Review: Why is Sage Therapeutics Inc stock going upQuarterly Portfolio Report & Low Drawdown Momentum Trade Ideas - خودرو بانک
Market Catalysts: How cyclical is Sage Therapeutics Inc.’s revenue streamBull Run & Breakout Confirmation Alerts - خودرو بانک
Rate Cut: Is LCNB Corp still a buy after recent gainsShare Buyback & Weekly Stock Performance Updates - khodrobank.com
Guidance Update: What are the future prospects of Sage Therapeutics IncWeekly Stock Recap & Expert Curated Trade Setup Alerts - خودرو بانک
Exit Recap: Why is Sage Therapeutics Inc stock going up2025 Big Picture & High Accuracy Swing Entry Alerts - خودرو بانک
Gainers Report: Will Sage Therapeutics Inc. benefit from current market trendsPortfolio Growth Summary & Weekly Chart Analysis and Guides - خودرو بانک
Gainers Report: Can DSS Inc outperform under higher oil pricesQuarterly Market Summary & Daily Stock Trend Reports - خودرو بانک
Aug Ideas: Can Sage Therapeutics Inc. reach resistance levels soonJuly 2025 Snapshot & Stock Portfolio Risk Management - خودرو بانک
Institution Moves: What are Sage Therapeutics Inc.’s technical support levelsWall Street Watch & Low Risk Entry Point Tips - خودرو بانک
Chipmakers Recap: What are the future prospects of Sage Therapeutics IncWeekly Investment Summary & Weekly Top Gainers Alerts - خودرو بانک
Surprises Report: Can Sage Therapeutics Inc deliver consistent dividendsGlobal Markets & Daily Chart Pattern Signals - خودرو بانک
Sage Therapeutics, Inc. (SAGE) Bought by Supernus to Boost Neuropsychiatric Portfolio - MSN
Published on: 2025-09-08 15:36:12 - beatles.ru
Can Traders Expect Breakout From Sage Therapeutics Inc. This Week2025 Institutional Moves & Reliable Momentum Entry Alerts - beatles.ru
How cyclical is Sage Therapeutics Inc.’s revenue stream2025 Sector Review & Real-Time Price Movement Reports - beatles.ru
Applying Elliott Wave Theory to Sage Therapeutics Inc.Inflation Watch & Free Expert Verified Stock Movement Alerts - Newser
Will Sage Therapeutics Inc. benefit from current market trendsMarket Rally & Low Risk Entry Point Tips - خودرو بانک
Will breakout in Sage Therapeutics Inc. lead to full recoveryJuly 2025 Fed Impact & Daily Chart Pattern Signal Reports - Newser
Will Sage Therapeutics Inc. stock go up in YEARMarket Movement Recap & Consistent Income Trade Ideas - خودرو بانک
Is Sage Therapeutics Inc. stock undervalued right nowRecession Risk & Free Fast Gain Swing Trade Alerts - خودرو بانک
Will Sage Therapeutics Inc. be affected by tariffsSwing Trade & Technical Entry and Exit Alerts - خودرو بانک
Can Sage Therapeutics Inc. sustain its profitabilityQuarterly Profit Review & Growth Focused Entry Point Reports - خودرو بانک
Inflation Data: Can Sage Therapeutics Inc. sustain its profitability2025 Market Outlook & Weekly Stock Breakout Alerts - خودرو بانک
Does Palvella Therapeutics Inc. have strong EBITDA marginsMarket Sentiment Report & Technical Pattern Based Buy Signals - خودرو بانک
Visualizing Sage Therapeutics Inc. stock with heatmapsWeekly Volume Report & Technical Analysis for Trade Confirmation - Newser
Is Sage Therapeutics Inc. exposed to currency risksWeekly Trade Summary & Stock Timing and Entry Methods - خودرو بانک
Layoff Tracker: Novo Cuts 9,000 Employees, Including 5,000 in Denmark - BioSpace
What the charts say about Sage Therapeutics Inc. todayEarnings Recap Summary & Growth Focused Stock Pick Reports - Newser
Can Sage Therapeutics Inc. reach all time highs this yearJuly 2025 Breakouts & Free Real-Time Market Sentiment Alerts - خودرو بانک
Supernus Pharmaceuticals Gets Retail Excited Over $795M Acquisition Plan For Sage Therapeutics - MSN
Combining machine learning predictions for Sage Therapeutics Inc.Weekly Trend Summary & AI Based Trade Execution Alerts - Newser
Top chart patterns to watch in Sage Therapeutics Inc.Swing Trade & Smart Investment Allocation Tips - Newser
Can momentum traders help lift Sage Therapeutics Inc.July 2025 Price Swings & Free Weekly Chart Analysis and Trade Guides - Newser
Developing predictive dashboards with Sage Therapeutics Inc. dataJuly 2025 Short Interest & Weekly Chart Analysis and Guides - Newser
Why is Sage Therapeutics Inc. stock going upPortfolio Performance Summary & Daily Stock Trend Watchlist - خودرو بانک
Big Money Moves: Can Sage Therapeutics Inc. reach resistance levels soonQuarterly Trade Report & Low Risk Investment Opportunities - خودرو بانک
How to forecast Sage Therapeutics Inc. trends using time seriesWeekly Investment Recap & Smart Investment Allocation Tips - Newser
Live market analysis of Sage Therapeutics Inc.July 2025 Action & Smart Swing Trading Techniques - Newser
What are Sage Therapeutics Inc.’s technical support levels2025 Dividend Review & AI Forecasted Entry and Exit Points - خودرو بانک
Should you hold or exit Sage Therapeutics Inc. nowEarnings Summary Report & Safe Capital Growth Stock Tips - Newser
Analyzing Sage Therapeutics Inc. with multi timeframe charts2025 Risk Factors & Expert Approved Momentum Ideas - Newser
Market reaction to Sage Therapeutics Inc.’s recent newsDay Trade & Weekly Return Optimization Plans - Newser
Is it too late to sell Sage Therapeutics Inc.Earnings Recap Report & Technical Confirmation Trade Alerts - Newser
Best data tools to analyze Sage Therapeutics Inc. stockJuly 2025 Price Swings & Weekly Hot Stock Watchlists - Newser
Will Sage Therapeutics Inc. benefit from green energy policiesLayoff News & Community Verified Trade Signals - خودرو بانک
MACD Cross Could Confirm Trend in Sage Therapeutics Inc.2025 Fundamental Recap & Verified Stock Trade Ideas - beatles.ru
Will Sage Therapeutics Inc. rebound enough to break evenJuly 2025 Selloffs & Risk Managed Investment Signals - Newser
Investors in Sage Therapeutics, Inc. Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your RightsSAGE - ACCESS Newswire
Sage Therapeutics Inc Stock (SAGE) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.97%
1.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):